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Abstract
Renal calcium reabsorption involves the epithelial
calcium channel ECaC1 (TRPV5) which is tightly
regulated by 1,25(OH)2D3. As shown recently, TRPV5
is activated by the serum and glucocorticoid inducible
kinase SGK1, a kinase transcriptionally upregulated
by 1,25(OH)2D3. This stimulatory effect is due to
enhanced TRPV5 abundance in the plasma
membrane and requires the presence of the scaffold
protein NHERF2 (sodium hydrogen exchanger
regulating factor 2). The present study aims to define
the molecular requirements for the interaction of
TRPV5 with SGK1 and NHERF2. Pull-down
experiments and overlay assays revealed that the
TRPV5 C-tail interacts in a Ca2+-independent manner
with NHERF2. Deletion of the second but not of the
first PDZ domain in NHERF2 abrogates the stimulating
effect of SGK1/NHERF2 on TRPV5 protein abundance
in the plasma membrane as quantified by
chemiluminescence and electrophysiology. Thus, the
second PDZ domain in NHERF2 is required for
stabilization at or TRPV5 targeting to the plasma
membrane. The experiments demonstrate the
significance of SGK1 and NHERF2 as TRPV5
modulators which are likely to participate in the
regulation of calcium homeostasis by 1,25(OH)2D3.
Introduction
The epithelial Ca2+ channel TRPV5/ECaC1 plays a
key role in both, intestinal absorption and renal reabsorption
of Ca2+[1, 2]. The channel accomplishes Ca2+ uptake
across the apical membrane of epithelial cells.
Subsequently Ca2+ is extruded via the basolateral Ca2+
ATPase and Na+/Ca2+ exchange [3]. Transcellular
transport of Ca2+ is modulated by 1,25(OH)2D3 (calcitriol),
the active metabolite of vitamin D3, which has further
been shown to influence differentiation and proliferation
of epithelial cells [4]. The importance of 1,25(OH)2D3 in
Ca2+ homeostasis of the body is reflected by the
development of rickets in patients with mutations in the
genes coding for the 1,25(OH)2D3-receptor [5] and for
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1α-hydroxylase [6]. The 1α-hydroxylase controls
1,25(OH)2D3 synthesis from 25-hydroxyvitamin D3
(calcidiol) which is in turn synthesized from vitamin D3
(cholecalciferol) by 25-hydroxylase.
As entry via TRPV5 is the rate limiting step in
transcellular transport of Ca2+, TRPV5 activity is decisive
for transepithelial transport regulation [7]. The C-terminal
tail of TRPV5 contains a PDZ binding motif which may
bind to the NHE regulating factors NHERF1 or NHERF2
[8]. NHERF1 and NHERF2 modulate the targeting and
trafficking of several proteins including TRPV4 to the
plasma membrane [9-11]. TRPV5 [12] and NHERF2 [13]
colocalize in principal cells.
Most recent experiments [14] disclosed a role of
serum and glucocorticoid dependent kinase SGK1 in the
interaction of TRPV5 with NHERF2. The kinase was
originally cloned as a glucocorticoid sensitive gene from
rat mammary tumor cells [15] and is genomically regulated
by 1,25(OH)2D3 [16]. Coexpression studies in Xenopus
oocytes revealed that TRPV5 conductance is activated
by the scaffold protein NHERF2 by increasing the channel
abundance at the plasma membrane. This stimulatory
effect requires the presence of the kinase SGK1 [14].
The present study has been performed to clarify the
role of PDZ domains (named for three proteins in which
this domain was first described: postsynaptic density PSD-
95/SAP90, the Drosophila septate junction protein disc-
large, and the tight junction protein ZO-1) in NHERF2 in
the regulation of TRPV5 activity.
To this end, cRNA encoding full-length TRPV5 has
been injected with or without wild type NHERF2,
NHERF2 lacking the first PDZ domain (NHERF2∆P1)
or NHERF2 lacking the second PDZ domain
(NHERF2∆P2) and/or constitutively active S422DSGK1
into Xenopus oocytes. We show here that the interaction
of NHERF2 and TRPV5 requires the second PDZ domain
of NHERF2 and the C-tail of TRPV5. Deletion of the
second but not of the first PDZ domain in NHERF2
abrogates the stimulating effect of SGK1/NHERF2 on
TRPV5 activity and abundance at the plasma membrane.
Thus, the second PDZ domain in NHERF2 is required
for TRPV5 stabilization at or TRPV5 targeting to the
plasma membrane.
Materials and Methods
GST-TRPV5 fusion protein and pull-down assays
The amino and carboxyl tails of mouse TRPV5 were
amplified by PCR using mouse kidney cDNA:
N tail: forward ccgaattcggatgggggctaaaactccttggatc;
reverse: cgcgctcgagctcaaggctgtccatatttcttccactt;
C tail: forward cccctgggatcc-ggcgacactcactggcgagtggcc;
reverse: acagaagtcgactcagaaatggtagatctcctc,
digested with EcoRI and XhoI (N tail) or BamHI and SalI
(C tail) and cloned into pGEX6p-2 (Amersham Pharmacia
Biotech AB, Uppsala, Sweden). pGEX6p-2 construct containing
full-length mouse NHERF2 was generously provided by Dr.
J. Biber. pGEX6p-2 constructs were transformed in Escherichia
coli BL21 and glutathione S-transferase (GST) fusion proteins
were expressed and purified according to the manufacturer’s
protocol (Amersham Pharmacia Biotech AB). [35S]methionine-
labeled full-length TRPV5 and NHERF2 were prepared using a
reticulocyte lysate system in the presence of canine microsomal
membranes (Promega Madison, WI) and added to GST or GST-
fusion proteins immobilized on glutathione-sepharose 4B beads.
The binding buffer contained 20 mM Tris-HCl pH 7.4, 140 mM
NaCl, 0.2 % (v/v) Triton-X-100 and 0.2% (v/v) NP-40,
supplemented with 1 mM CaCl2 or 2 mM EDTA. After 2 h
incubation at room temperature, the beads were washed
extensively with binding buffer. Bound proteins were eluted
with SDS-PAGE loading buffer, separated on SDS-PAGE gels
and visualized by autoradiography.
Overlay assays
Approximately 10 µg GST, GST-TRPV5 C-tail, GST-TRPV6
C-tail, GST-NHERF2 or bovine serum albumin were separated
on SDS/PAGE gels and blotted into PVDF membranes. Blots
were blocked for 60 min in binding buffer containing 20 mM
Tris-HCl pH 7.4, 140 mM NaCl, 1 mM CaCl2, 0.2 % (v/v) Triton-
X-100 and 3 % (w/v) BSA. Subsequently, blots were incubated
with in vitro translated [35S]-labeled NHERF2 or TRPV5 for 2 h
at room temperature in binding buffer containing 0.3 % (w/v)
BSA, washed extensively and bound proteins were visualized
by autoradiography.
Expression in Xenopus laevis oocytes
cRNA encoding rabbit TRPV5 [1], human NHERF2 [17],
NHERF2 lacking the first PDZ domain (NHERF2∆P1) or
NHERF2 lacking the second PDZ domain (NHERF2∆P2) and
constitutively active human S422DSGK1 have been synthesized
as described [18]. Oocytes were injected with 2.5 ng TRPV5,
7.5 ng S422DSGK1 and/or 5 ng NHERF2 or NHERF2∆P1 or
NHERF2∆P2 cRNA or H2O. All experiments were performed at
room temperature 3 days after injection of the respective
cRNAs.
Voltage-clamp analysis
In two-electrode voltage-clamp experiments currents were
recorded during a 4 s linear voltage ramp from –150 mV to +50
mV. The intermediate holding potential between the voltage
ramps was -50 mV. Data were filtered at 10 Hz and recorded with
MacLab digital to analog converter and software for data
acquisition and analysis (ADInstruments, Castle Hill, Australia).
The bath solution contained 96 mM NaCl, 2 mM KCl, 1 mM
MgCl2, 1mM BaCl2,10 µM methoxyverapamil, 5 mM HEPES, pH
7.4 with or without 10 mM CaCl2. Oocytes were kept in modified
Barth´s solution containing 88 mM NaCl, 1 mM KCl, 2.4 mM
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NaHCO3, 0.8 mM MgSO4, 0.3 mM Ca(NO3)2, 0.4 mM CaCl2 and
5 mM HEPES, pH 7.4 supplemented with 25 µg/ml gentamycin.
The final solutions were titrated to the pH indicated using HCl
or NaOH. The flow rate of the superfusion was 20 ml/min and a
complete exchange of the bath solution was reached within
about 10 s. The addition of 10 mM CaCl2 induced an inward
current (ICl(Ca)) which was created by entry of Ca2+ and
subsequent activation of Ca2+ sensitive Cl- channels [1]. The
peak inward current was taken as a measure for TRPV5 activity.
The currents depicted in the figures represent the maximum
peak inward current from a voltage ramp ranging from -150 mV
to +50 mV in the presence of 10 mM Ca2+. The intermediate
holding potential was –50 mV. ICl(Ca) activity is synchronously
triggered by the intracellular calcium concentration close to
the membrane determined by the epithelial calcium channel
TRPV5. Thus, ICl(Ca) activity mirrors activation and inactivation
kinetics of TRPV5 [19].
Detection of cell surface expression by
chemiluminescence
Defolliculated oocytes were first injected with S422DSGK1
cRNA (7.5 ng/oocyte) and/or NHERF2, NHERF2∆P1 or
NHERF2∆P2 cRNA (5 ng/oocyte), and one day later with
TRPV5-HA (25 ng/oocyte) which contains an HA
(hemagglutinin) epitope extracellularly between amino acid 376
and 377. Oocytes were incubated with 1 µg/ml primary rat
monoclonal anti-HA antibody (clone 3F10, Boehringer,
Germany), and 2 µg/ml secondary, peroxidase-conjugated
affinity-purified F(ab’)2 goat anti-rat IgG antibody (Jackson
ImmunoResearch, West Grove, USA). Individual oocytes were
placed in 20 µl of SuperSignal ELISA Femto Maximum
Sensitivity Substrate (Pierce, Rockford, USA), and
chemiluminescence was quantified in a luminometer by
integrating the signal over a period of 1 s. Results are given in
relative light units (RLU).
Statistics
Data are provided as means ± SEM, n represents the
number of oocytes investigated. All experiments were repeated
with at least 3 batches of oocytes from different frogs; in all
repetitions qualitatively similar data were obtained. All data
were tested for significance using ANOVA, and only results
with P < 0.05 were considered statistically significant.
Results
In the presence of Cl- the Ca2+ entry through TRPV5
activated Ca2+ sensitive Cl- channels leading to the
appearance of a large Cl- current (ICl(Ca)). In TRPV5
expressing oocytes, coexpression of NHERF2 together
with S422DSGK1 stimulated ICl(Ca) from 0.26 ± 0.08 µA in
TRPV5 expressing oocytes (n = 24) to 0.78 ± 0.09 µA in
oocytes expressing S422DSGK1/NHERF2/TRPV5 (n = 24,
3 animals) (Fig. 1).
Fig. 1. Stimulation of Ca2+ currents by the combined expression
of TRPV5, NHERF2 and the S422DSGK1. TRPV5 mediated calcium
currents indirectly activate an endogenous chloride
conductance (ICl(Ca)). The depicted ICl(Ca) is the maximum peak
inward current from a voltage ramp ranging from -150 mV to
+50 mV in the presence of 10 mM Ca2+. The intermediate holding
potential was –50 mV. ICl(Ca) was stimulated by coexpression of
TRPV5 together with NHERF2 and S422DSGK1. Coexpression of
TRPV5 with either NHERF2 or S422DSGK1 alone did not
significantly enhance ICl(Ca). * denotes significant difference
(p < 0.05) between Xenopus oocytes expressing TRPV5 together
with S422DSGK1 and NHERF2 and oocytes expressing TRPV5
alone. n = 21 – 24 oocytes from 3 animals.
To investigate whether the regulatory effect of
NHERF2 and S422DSGK1 on TRPV5 activity is mediated
by protein-protein interaction of NHERF2 and TRPV5,
pull-down and overlay assays were performed. To this
end, full-length TRPV5 protein was labeled with
[35S]methionine by in vitro transcription/translation and
its interaction with NHERF2 was tested under in vitro
conditions. As shown in Fig. 2A, TRPV5 interacted with
GST-NHERF2 fusion protein, whereas no binding to GST
alone was observed, indicating the specificity of the
interaction. The binding was identical in the presence or
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Fig. 3. NHERF2 interacts with TRPV5 through the TRPV5
carboxyl tail. GST fusion proteins encompassing either the
amino or carboxyl tail of TRPV5 or TRPV6 were purified from E.
coli and immobilized on glutathione-sepharose 4B beads (in
A, B) or blotted onto PVDF membranes (in C) and incubated
with in vitro translated [35S]methionine-labeled NHERF2.
Bound proteins were analyzed by autoradiography. NHERF2
interacts in a Ca2+- independent manner with TRPV5 C-tail,
whereas no binding with GST and TRPV6 is observed indicating
the specificity of the interaction.
Fig. 2. Interaction of NHERF2 with TRPV5 as demonstrated
by GST pull-down and overlay assays. Full-length NHERF2
expressed as GST fusion protein was purified from E. coli and
immobilized on glutathione-sepharose 4B beads (in A) or
blotted onto PVDF membranes (in B) and incubated with in
vitro translated [35S]methionine-labeled TRPV5. Bound proteins
were analyzed by autoradiography. NHERF2 interacts in a Ca2+-
independent manner with TRPV5, whereas no binding with
GST and BSA was observed.
absence (2 mM EDTA) of Ca2+ (1 mM). Results obtained
were corroborated by overlay assays. In vitro translated
[35S]-labeled TRPV5 bound GST-NHERF2, whereas
GST alone and bovine serum albumin (BSA) showed no
interaction (Fig. 2B).
To demonstrate that the interaction between TRPV5
and NHERF2 ocurred via the carboxyl tail of TRPV5,
we amplified the amino and carboxyl tails of mouse
TRPV5 by PCR using mouse kidney cDNA. GST fusion
proteins encompassing either the amino or carboxyl tail
of TRPV5 were incubated with [35S]methionine-labeled
NHERF2. NHERF2 interacted specifically with the
carboxyl tail, while the amino tail of TRPV5 was unable
to bind NHERF2. The binding was again Ca2+-
independent (Fig. 3A). To verify the specificity of
TRPV5/NHERF2 interaction we performed experiments
with the TRPV5 isoform TRPV6. Fig. 3B shows that
neither the amino nor the carboxyl tail of TRPV6
interacted with [35S]methionine-labeled NHERF2.
Overlay assays with in vitro translated [35S]-labeled
NHERF2 confirmed the selective ability of NHERF2 to
bind TRPV5 C-tail (Fig. 3C).
Further studies were performed to identify the PDZ
binding domain of NHERF2 required for the stimulating
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Fig. 4. Requirement of the second PDZ domain of NHERF2
for the stimulation of TRPV5 by constitutively active S422DSGK1.
Xenopus laevis oocytes were injected with water or cRNA
encoding TRPV5 alone or with S422DSGK1 and either wild-type
NHERF2, NHERF2 lacking the second PDZ domain
(NHERF2∆P2) or NHERF2 lacking the first PDZ domain
(NHERF2∆P1). Only the combined coexpression of S422DSGK1
and wild-type NHERF2 or NHERF2∆P1 increases ICl(Ca). The
depicted ICl(Ca) is the maximum peak inward current from a voltage
ramp ranging from -150 mV to +50 mV in the presence of 10 mM
Ca2+. The intermediate holding potential was –50 mV. * indicate
significant difference between expression of TRPV5 alone and
of TRPV5 coexpressed with S422DSGK1 and NHERF2. n = 14 – 15
oocytes from 3 animals.
effect of S422DSGK1 and NHERF2 on TRPV5 activity.
As shown in Fig. 4, TRPV5 channel activity was
enhanced with both, S422DSGK1 and wild-type NHERF2
(from 1.90 ± 0.44 µA to 7.04 ± 0.83 µA, n = 15), but not
by coexpression of TRPV5 together with S422DSGK1 and
NHERF2 lacking the second PDZ domain NHERF2∆P2.
In contrast, coexpression of S422DSGK1 together with a
NHERF2 mutant deficient of the first PDZ domain
(NHERF2∆P1) increased TRPV5 activity similar to
coexpression of S422DSGK1 together with wild type
NHERF2 (from 1.90 ± 0.44 µA to 6.0 ± 0.81 µA, n = 14,
3 animals). Thus, the second but not the first PDZ domain
is essential for upregulation of TRPV5 activity. This
requirement for the second PDZ domain is consistent
with the interaction of SGK1 with the second but not first
PDZ domain of NHERF2.
The PDZ domains of NHERF2 are thought to link
NHERF2 and associated proteins to the cytoskeleton and
thus to accomplish the targeting to or stabilization of
transport proteins at the cell membrane. Therefore we
examined TRPV5 surface expression, using a
chemiluminescence assay in parallel with electro-
physiological measurements, upon coexpression of
S422DSGK1 and NHERF2 mutants. Fig. 5 demonstrates
that both surface expression and current are increased in
oocytes expressing S422DSGK1/NHERF2/TRPV5
compared to TRPV5 control oocytes. Co-expression of
S422DSGK1/NHERF2 enhanced TRPV5 surface labelling
by 4.4 fold and TRPV5-mediated currents from 1.87 ±
0.41 µA in TRPV5 expressing oocytes (n = 21) to 7.01 ±
1.27 µA in oocytes expressing S422DSGK1/NHERF2/
TRPV5 (n = 20). TRPV5 surface expression was also
stimulated up to 3.5 fold upon coexpression of S422DSGK1
and NHERF2 lacking the first PDZ domain
(NHERF2∆P1). However, co-expression of NHERF2
lacking the second PDZ domain failed to increase TRPV5
expression and TRPV5-mediated currents 1.87 ±
0.41 µA in TRPV5 expressing oocytes (n = 21) versus
2.42 ± 0.41 µA in oocytes expressing S422DSGK1/
NHERF2∆P2/TRPV5 (n = 20, 3 animals).
Discussion
The present experiments confirm the previous
observations disclosing a completely novel mechanism
regulating TRPV5 activity, i.e. the regulation by the NHE
regulating factor NHERF2 and the serum and
glucocorticoid inducible kinase SGK1 [14].
As shown in this study, NHERF2 binds to the
carboxyl tail of TRPV5 and requires its second PDZ
domain to be effective. NHERF2 is thought to link
membrane proteins to cytoskeletal proteins through its
PDZ domains [17, 20]. The binding to the cytoskeleton
may serve to target or stabilize the protein at the cell
membrane. We demonstrate that deletion of the second
but not of the first PDZ domain in NHERF2 abrogates
the stimulating effect of SGK1/NHERF2 on TRPV5
protein abundance at the plasma membrane. Thus, the
second PDZ domain in NHERF2 is required for TRPV5
stabilization at or TRPV5 targeting to the plasma
membrane.
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NHERF2 and SGK1 modulate TRPV5 and not the
Ca2+-activated Cl- channels, since intrinsic NPPB
sensitive chloride current remains unaffected upon SGK1
and/or NHERF2 coexpression [14]. The effect of SGK1
depends on an intact catalytic subunit as the inactive
mutant K127NSGK1 did not influence TRPV5 even in the
presence of NHERF2 [14]. Thus, the kinase is obviously
effective through phosphorylation of the target protein.
SGK1 has been reported to bind NHERF2 [8]. However,
SGK1 cannot phosphorylate NHERF2 (unpublished
observations). TRPV5 possess a putative SGK1
phosphorylation site in its sequence. Hence, SGK1 might
phosphorylate and thereby stimulate TRPV5 activity.
Nevertheless this stimulatory effect requires NHERF2
which, similar to what has been described for the
modulation of NHE3 by PKA [8], might bind SGK1 to
bring the kinase in close proximity to TRPV5 or an
associated protein.
A well known function of SGK1 is its participation
in the regulation of the epithelial Na+ channel ENaC [21-
30]. SGK1 is effective by increasing the abundance of
the ENaC protein within the cell membrane [21, 30, 31].
Most recently, SGK1 has been shown to upregulate the
renal epithelial K+ channel ROMK1 [32]. Similar to SGK-
dependent regulation of TRPV5, the regulation of ROMK1
by SGK1 has been shown to depend on NHERF2 and on
the PDZ binding motif present in ROMK1. TRPV5, as
well as ROMK1, display an exquisite H+ sensitivity [1,
16, 33, 34]. TRPV5 activity is markedly reduced by
lowering of the ambient pH. Thus, NHERF2 could
Fig. 5. Requirement of the
second PDZ domain of NHERF2
for the stimulation of TRPV5 cell
surface expression by constitu-
tively active S422DSGK1. Xenopus
laevis oocytes were injected with
water or cRNA encoding TRPV5
alone or with S422DSGK1 and either
wild-type NHERF2, NHERF2
lacking the second PDZ domain
(NHERF2∆P2) or NHERF2
lacking the first PDZ domain
(NHERF2∆P1). A) Only the com-
bined coexpression of S422DSGK1
and wild-type NHERF2 or
NHERF2∆P1 increases TRPV5
cell surface expression. * indicate
significant difference between
expression of TRPV5 alone and
of TRPV5 coexpressed with
S422DSGK1 and NHERF2. n = 20 -
29 oocytes from 3 animals. B) Cell
surface expression correlates
with TRPV5 whole cell current.
n = 20 - 29 oocytes from 3 animals.
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participate in the link between TRPV5 activity and acid
base balance. The sensitivity of renal tubular Ca2+
transport to H+ is of physiological significance, since on
the one hand mineralization of bone depends on the
deposition of highly alkaline Ca2+ salts [35] and on the
other hand precipitation of Ca2+ phosphate salts is
favoured by alkalinization of urine [36].
In contrast to the regulation of TRPV5, NHE3 [37]
and ROMK1 [32], the regulation of ENaC does not require
the participation of NHERF2. SGK1 stimulates ENaC in
part by phosphorylating the ubiquitin protein ligase Nedd4-
2 in a PY motif-dependent manner [38, 39]. The
phosphorylation impedes the binding of Nedd4-2 to ENaC
[38]. The ENaC sequence does not include a PDZ motif,
suggesting that NHERF2 can not directly interact with
ENaC.
In conclusion, TRPV5 is the target of a complex
regulating mechanism involving both, the NHE regulating
factor NHERF2 and the serine/threonine kinase SGK1.
The concerted action of NHERF2 and the kinase markedly
upregulates the activity and plasma membrane abundance
of this key channel in the regulation of Ca2+ homeostasis.
The stimulatory effect requires the second PDZ domain
of NHERF2 and the carboxyl tail of TRPV5.
Abbreviations
GST (glutathione S-transferase); SGK (serum and
glucocorticoid inducible kinase); PVDF (Polyvinylidene
Fluoride); NHERF (sodium hydrogen exchanger
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